Published in EMBO Mol Med on October 16, 2012
HIF-1α Promotes Epithelial-Mesenchymal Transition and Metastasis through Direct Regulation of ZEB1 in Colorectal Cancer. PLoS One (2015) 1.02
Integrin α6A splice variant regulates proliferation and the Wnt/β-catenin pathway in human colorectal cancer cells. Carcinogenesis (2014) 0.96
Investigation of the essential role of platelet-tumor cell interactions in metastasis progression using an agent-based model. Theor Biol Med Model (2014) 0.82
MRC-5 fibroblast-conditioned medium influences multiple pathways regulating invasion, migration, proliferation, and apoptosis in hepatocellular carcinoma. J Transl Med (2015) 0.80
Deletion of Ptp4a3 reduces clonogenicity and tumor-initiation ability of colitis-associated cancer cells in mice. Stem Cell Res (2014) 0.79
Phosphatase of regenerating liver: a novel target for cancer therapy. Expert Opin Ther Targets (2014) 0.79
Ligand-targeted theranostic nanomedicines against cancer. J Control Release (2016) 0.77
Luminescent silica nanoparticles for cancer diagnosis. Curr Med Chem (2013) 0.77
Integrin α6 promotes esophageal cancer metastasis and is targeted by miR-92b. Oncotarget (2016) 0.76
Hallmarks of cancer: the next generation. Cell (2011) 140.01
Global cancer statistics, 2002. CA Cancer J Clin (2005) 119.22
Bioinformatics enrichment tools: paths toward the comprehensive functional analysis of large gene lists. Nucleic Acids Res (2008) 54.83
Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer. N Engl J Med (2004) 49.02
A genetic model for colorectal tumorigenesis. Cell (1990) 44.37
Genetic alterations during colorectal-tumor development. N Engl J Med (1988) 26.82
Complex networks orchestrate epithelial-mesenchymal transitions. Nat Rev Mol Cell Biol (2006) 23.04
Macrophages: obligate partners for tumor cell migration, invasion, and metastasis. Cell (2006) 13.79
Cetuximab for the treatment of colorectal cancer. N Engl J Med (2007) 13.39
Searching for peptide ligands with an epitope library. Science (1990) 10.75
Genes that mediate breast cancer metastasis to the brain. Nature (2009) 8.23
Metastasis results from preexisting variant cells within a malignant tumor. Science (1977) 6.47
Distinct organ-specific metastatic potential of individual breast cancer cells and primary tumors. J Clin Invest (2005) 6.10
Adhesion between epithelial cells and T lymphocytes mediated by E-cadherin and the alpha E beta 7 integrin. Nature (1994) 5.73
Rescue surgery for unresectable colorectal liver metastases downstaged by chemotherapy: a model to predict long-term survival. Ann Surg (2004) 5.10
Actual 10-year survival after resection of colorectal liver metastases defines cure. J Clin Oncol (2007) 4.95
Integrin ligands at a glance. J Cell Sci (2006) 4.76
Beta 4 integrin amplifies ErbB2 signaling to promote mammary tumorigenesis. Cell (2006) 4.48
Libraries of peptides and proteins displayed on filamentous phage. Methods Enzymol (1993) 4.10
E-cadherin suppresses cellular transformation by inhibiting beta-catenin signaling in an adhesion-independent manner. J Cell Biol (2001) 4.04
A phosphatase associated with metastasis of colorectal cancer. Science (2001) 3.86
Steps toward mapping the human vasculature by phage display. Nat Med (2002) 3.82
Mesenchymal-to-epithelial transition facilitates bladder cancer metastasis: role of fibroblast growth factor receptor-2. Cancer Res (2006) 3.12
The natural history of hepatic metastases from colorectal cancer. A comparison with resective treatment. Ann Surg (1984) 3.08
The secreted factors responsible for pre-metastatic niche formation: old sayings and new thoughts. Semin Cancer Biol (2011) 2.83
Combined transcriptome and genome analysis of single micrometastatic cells. Nat Biotechnol (2002) 2.48
Tumor-host interactions: a far-reaching relationship. J Clin Oncol (2010) 2.48
Targeting angiogenesis: progress with anti-VEGF treatment with large molecules. Nat Rev Clin Oncol (2009) 2.41
Epithelial integrin alpha 6 beta 4: complete primary structure of alpha 6 and variant forms of beta 4. J Cell Biol (1990) 2.24
E-cadherin as an indicator of mesenchymal to epithelial reverting transitions during the metastatic seeding of disseminated carcinomas. Clin Exp Metastasis (2008) 2.21
Hepatic expression, synthesis and secretion of a novel fibrinogen/angiopoietin-related protein that prevents endothelial-cell apoptosis. Biochem J (2000) 2.09
Adaptation versus selection: the origins of metastatic behavior. Cancer Res (2007) 2.08
Current and emerging concepts in tumour metastasis. J Pathol (2010) 1.88
Changing neighbours, changing behaviour: cell adhesion molecule-mediated signalling during tumour progression. EMBO J (2003) 1.84
Proteoglycans in health and disease: novel roles for proteoglycans in malignancy and their pharmacological targeting. FEBS J (2010) 1.83
Clonal selection of metastasis within the life history of a tumor. Cancer Res (2007) 1.74
PRL-3 expression in metastatic cancers. Clin Cancer Res (2003) 1.73
The alpha 6 beta 4 integrin and epithelial cell migration. Curr Opin Cell Biol (2001) 1.71
Osteopontin N-terminal domain contains a cryptic adhesive sequence recognized by alpha9beta1 integrin. J Biol Chem (1996) 1.64
Angiopoietin-related growth factor antagonizes obesity and insulin resistance. Nat Med (2005) 1.61
An osteopontin fragment is essential for tumor cell invasion in hepatocellular carcinoma. Oncogene (2007) 1.57
Epithelial-mesenchymal transition mediated tumourigenesis in the gastrointestinal tract. World J Gastroenterol (2008) 1.51
Discovery and scoring of protein interaction subnetworks discriminative of late stage human colon cancer. Mol Cell Proteomics (2008) 1.43
Alpha E beta 7 integrin interaction with E-cadherin promotes antitumor CTL activity by triggering lytic granule polarization and exocytosis. J Exp Med (2007) 1.42
Experimental nude mouse model of human colorectal cancer liver metastases. J Natl Cancer Inst (1986) 1.38
Organ-specific modulation of steady-state mdr gene expression and drug resistance in murine colon cancer cells. J Natl Cancer Inst (1994) 1.37
Complex interactions between the laminin alpha 4 subunit and integrins regulate endothelial cell behavior in vitro and angiogenesis in vivo. Proc Natl Acad Sci U S A (2002) 1.31
Panitumumab. Nat Rev Drug Discov (2006) 1.31
Aminopeptidase A is a functional target in angiogenic blood vessels. Cancer Cell (2004) 1.28
Beta4 integrin is a transforming molecule that unleashes Met tyrosine kinase tumorigenesis. Cancer Res (2005) 1.20
Liver colonization competence governs colon cancer metastasis. Proc Natl Acad Sci U S A (1995) 1.17
Insulin-like growth factor-I receptor, E-cadherin and alpha v integrin form a dynamic complex under the control of alpha-catenin. Int J Cancer (2008) 1.15
Traction forces mediated by alpha6beta4 integrin: implications for basement membrane organization and tumor invasion. Mol Biol Cell (2001) 1.08
Phosphorylation of a novel site on the {beta}4 integrin at the trailing edge of migrating cells promotes hemidesmosome disassembly. Mol Biol Cell (2008) 1.05
Structural elements of the osteopontin SVVYGLR motif important for the interaction with alpha(4) integrins. FEBS Lett (2001) 1.05
E-cadherin expression pattern in primary colorectal carcinomas and their metastases reflects disease outcome. World J Gastroenterol (2006) 1.03
Allele loss, replication errors and loss of expression of E-cadherin in colorectal cancers. Gut (1997) 1.01
Angiopoietin-related growth factor (AGF) promotes angiogenesis. Blood (2004) 1.00
Interpreting kinetic rate constants from optical biosensor data recorded on a decaying surface. Anal Biochem (1998) 1.00
Integrins can directly mediate metastatic tumor cell adhesion within the liver sinusoids. J Gastrointest Surg (2004) 0.99
Epidermal growth factor receptor in relation to tumor development: EGFR-targeted anticancer therapy. FEBS J (2009) 0.99
BIACORE data processing: an evaluation of the global fitting procedure. Anal Biochem (2001) 0.96
Angiopoietin-related growth factor enhances blood flow via activation of the ERK1/2-eNOS-NO pathway in a mouse hind-limb ischemia model. Arterioscler Thromb Vasc Biol (2008) 0.96
Immune cell infiltration of primary and metastatic lesions: mechanisms and clinical impact. Semin Cancer Biol (2010) 0.95
Liver metastases with 10 human colon carcinoma cell lines in nude mice and association with carcinoembryonic antigen production. Cancer (1993) 0.93
Differential gene expression profiles of metastases in paired primary and metastatic colorectal carcinomas. Oncology (2008) 0.92
Colorectal Cancer Treatment: What's Next? (or: Is There Life After EGFR and VEGF?). Gastrointest Cancer Res (2008) 0.90
Organ distribution of experimental metastases of a human colorectal carcinoma injected in nude mice. Clin Exp Metastasis (1989) 0.85
Angiopoietin-related growth factor (AGF) supports adhesion, spreading, and migration of keratinocytes, fibroblasts, and endothelial cells through interaction with RGD-binding integrins. Biochem Biophys Res Commun (2006) 0.82
Functional blocking of specific integrins inhibit colonic cancer migration. Clin Exp Metastasis (2009) 0.80
Interaction of integrin alpha(6)beta(4) with ErbB3 and implication in heregulin-induced ErbB3/ErbB2-mediated DNA synthesis. Genes Cells (2010) 0.78
Targeting the extracellular signature of metastatic colorectal cancers. Expert Opin Ther Targets (2009) 0.78
Expanding the natural history of nonalcoholic steatohepatitis: from cryptogenic cirrhosis to hepatocellular carcinoma. Gastroenterology (2002) 6.62
Chemotherapy regimen predicts steatohepatitis and an increase in 90-day mortality after surgery for hepatic colorectal metastases. J Clin Oncol (2006) 5.78
Effect of surgical margin status on survival and site of recurrence after hepatic resection for colorectal metastases. Ann Surg (2005) 4.86
Fibroblast growth factor/fibroblast growth factor receptor system in angiogenesis. Cytokine Growth Factor Rev (2005) 4.65
Posthepatectomy liver failure: a definition and grading by the International Study Group of Liver Surgery (ISGLS). Surgery (2011) 4.40
Pathologic response to preoperative chemotherapy: a new outcome end point after resection of hepatic colorectal metastases. J Clin Oncol (2008) 4.37
A population of multipotent CD34-positive adipose stromal cells share pericyte and mesenchymal surface markers, reside in a periendothelial location, and stabilize endothelial networks. Circ Res (2007) 4.34
Reversal of obesity by targeted ablation of adipose tissue. Nat Med (2004) 4.23
A molecularly annotated platform of patient-derived xenografts ("xenopatients") identifies HER2 as an effective therapeutic target in cetuximab-resistant colorectal cancer. Cancer Discov (2011) 3.86
Steps toward mapping the human vasculature by phage display. Nat Med (2002) 3.82
Class 3 semaphorins control vascular morphogenesis by inhibiting integrin function. Nature (2003) 3.42
Fingerprinting the circulating repertoire of antibodies from cancer patients. Nat Biotechnol (2002) 3.32
Genetic basis for in vivo daptomycin resistance in enterococci. N Engl J Med (2011) 3.20
Bile leakage after hepatobiliary and pancreatic surgery: a definition and grading of severity by the International Study Group of Liver Surgery. Surgery (2011) 3.16
Rates and patterns of recurrence following curative intent surgery for colorectal liver metastasis: an international multi-institutional analysis of 1669 patients. Ann Surg (2009) 3.15
Intravascular delivery of particulate systems: does geometry really matter? Pharm Res (2008) 3.13
Random peptide libraries displayed on adeno-associated virus to select for targeted gene therapy vectors. Nat Biotechnol (2003) 3.01
Cell surface expression of the stress response chaperone GRP78 enables tumor targeting by circulating ligands. Cancer Cell (2004) 2.99
A clinical outcome-based prospective study on venous thromboembolism after cancer surgery: the @RISTOS project. Ann Surg (2006) 2.97
Hepatic insufficiency and mortality in 1,059 noncirrhotic patients undergoing major hepatectomy. J Am Coll Surg (2007) 2.62
Measured versus estimated total liver volume to preoperatively assess the adequacy of the future liver remnant: which method should we use? Ann Surg (2013) 2.39
Prevention of hepatocellular carcinoma recurrence with alpha-interferon after liver resection in HCV cirrhosis. Hepatology (2006) 2.38
Systematic use of an intraoperative air leak test at the time of major liver resection reduces the rate of postoperative biliary complications. J Am Coll Surg (2013) 2.36
Shedding of the matrix metalloproteinases MMP-2, MMP-9, and MT1-MMP as membrane vesicle-associated components by endothelial cells. Am J Pathol (2002) 2.27
Simultaneous resections of colorectal cancer and synchronous liver metastases: a multi-institutional analysis. Ann Surg Oncol (2007) 2.26
A hybrid vector for ligand-directed tumor targeting and molecular imaging. Cell (2006) 2.20
Optimizing donor selection for public cord blood banking: influence of maternal, infant, and collection characteristics on cord blood unit quality. Transfusion (2013) 2.19
Neuropilin-1/GIPC1 signaling regulates alpha5beta1 integrin traffic and function in endothelial cells. PLoS Biol (2009) 2.16
Matrix metalloproteinases (MMP9 and MMP2) induce the release of vascular endothelial growth factor (VEGF) by ovarian carcinoma cells: implications for ascites formation. Cancer Res (2003) 2.14
Three-dimensional tissue culture based on magnetic cell levitation. Nat Nanotechnol (2010) 2.11
Functional role and prognostic significance of CD157 in ovarian carcinoma. J Natl Cancer Inst (2010) 2.08
Solitary colorectal liver metastasis: resection determines outcome. Arch Surg (2006) 2.06
Italian cross-cultural adaptation and validation of the Oxford Shoulder Score. J Shoulder Elbow Surg (2009) 2.02
Targeting the prostate for destruction through a vascular address. Proc Natl Acad Sci U S A (2002) 2.01
Bioavailability of VEGF in tumor-shed vesicles depends on vesicle burst induced by acidic pH. Neoplasia (2006) 1.98
Ghrelin and des-acyl ghrelin inhibit cell death in cardiomyocytes and endothelial cells through ERK1/2 and PI 3-kinase/AKT. J Cell Biol (2002) 1.97
Display technologies: application for the discovery of drug and gene delivery agents. Adv Drug Deliv Rev (2006) 1.92
Open-label, multicenter, randomized phase III trial of adjuvant chemoradiation plus interferon Alfa-2b versus fluorouracil and folinic acid for patients with resected pancreatic adenocarcinoma. J Clin Oncol (2012) 1.90
Complexity and complementarity of outer membrane protein A recognition by cellular and humoral innate immunity receptors. Immunity (2005) 1.86
Incidence of finding residual disease for incidental gallbladder carcinoma: implications for re-resection. J Gastrointest Surg (2007) 1.82
Modeling the early stages of vascular network assembly. EMBO J (2003) 1.78
White adipose tissue cells are recruited by experimental tumors and promote cancer progression in mouse models. Cancer Res (2009) 1.78
Differential binding of drugs containing the NGR motif to CD13 isoforms in tumor vessels, epithelia, and myeloid cells. Cancer Res (2002) 1.76
State of the art. Cellular and molecular mechanisms of alveolar destruction in emphysema: an evolutionary perspective. Proc Am Thorac Soc (2006) 1.75
A peptidomimetic targeting white fat causes weight loss and improved insulin resistance in obese monkeys. Sci Transl Med (2011) 1.74
Design and validation of a bifunctional ligand display system for receptor targeting. Chem Biol (2004) 1.73
Networks of gold nanoparticles and bacteriophage as biological sensors and cell-targeting agents. Proc Natl Acad Sci U S A (2006) 1.73
Bile leakage and liver resection: Where is the risk? Arch Surg (2006) 1.71
Hepatic resection for metastatic melanoma: distinct patterns of recurrence and prognosis for ocular versus cutaneous disease. Ann Surg Oncol (2006) 1.70
SPARC regulates extracellular matrix organization through its modulation of integrin-linked kinase activity. J Biol Chem (2005) 1.70
Integrins and angiogenesis: a sticky business. Exp Cell Res (2005) 1.69
A survival analysis of the liver-first reversed management of advanced simultaneous colorectal liver metastases: a LiverMetSurvey-based study. Ann Surg (2012) 1.69
Angiopoietin-2 expression in breast cancer correlates with lymph node invasion and short survival. Int J Cancer (2003) 1.69
Coronary microvascular pericytes are the cellular target of sunitinib malate-induced cardiotoxicity. Sci Transl Med (2013) 1.69
Early recurrence after liver resection for colorectal metastases: risk factors, prognosis, and treatment. A LiverMetSurvey-based study of 6,025 patients. Ann Surg Oncol (2013) 1.68
Phase II presurgical feasibility study of bevacizumab in untreated patients with metastatic renal cell carcinoma. J Clin Oncol (2009) 1.67
Next-generation phage display: integrating and comparing available molecular tools to enable cost-effective high-throughput analysis. PLoS One (2009) 1.66
Sema4D induces angiogenesis through Met recruitment by Plexin B1. Blood (2005) 1.65
Synchronous selection of homing peptides for multiple tissues by in vivo phage display. FASEB J (2006) 1.63
Novel binding partners of Ldb1 are required for haematopoietic development. Development (2006) 1.63
Regulator of G-protein signaling 5 (RGS5) protein: a novel marker of cancer vasculature elicited and sustained by the tumor's proangiogenic microenvironment. Cell Mol Life Sci (2011) 1.62
Extending the phenotypes associated with DICER1 mutations. Hum Mutat (2011) 1.61
Stable interaction between alpha5beta1 integrin and Tie2 tyrosine kinase receptor regulates endothelial cell response to Ang-1. J Cell Biol (2005) 1.61
Timing of resection of liver metastases synchronous to colorectal tumor: proposal of prognosis-based decisional model. Ann Surg Oncol (2007) 1.61
HIV protease inhibitors are potent anti-angiogenic molecules and promote regression of Kaposi sarcoma. Nat Med (2002) 1.59
Ethics guidelines for research with the recently dead. Nat Med (2005) 1.56
Semaphorin 3A is an endogenous angiogenesis inhibitor that blocks tumor growth and normalizes tumor vasculature in transgenic mouse models. J Clin Invest (2009) 1.56
Post-hepatectomy haemorrhage: a definition and grading by the International Study Group of Liver Surgery (ISGLS). HPB (Oxford) (2011) 1.56
Combinatorial screenings in patients: the interleukin-11 receptor alpha as a candidate target in the progression of human prostate cancer. Cancer Res (2004) 1.56